Litcius/Paper detail

NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker

Raul Perret, Julien Escuriol, Valérie Velasco, Laétitia Mayeur, Isabelle Soubeyran, Christophe Delfour, Sébastien Aubert, Marc Polivka, Marie Karanian, Alexandra Meurgey, Sophie Le Guellec, Noëlle Weingertner, Sylvia Hoeller, Jean‐Michel Coindre, Fréderique Larousserie, Gaëlle Pierron, Franck Tirode, François Le Loarer

2020Modern Pathology58 citationsDOIOpen Access PDF

Topics & Concepts

CD99PathologyOsteoidPleomorphism (cytology)ImmunohistochemistryMedicineSarcomaSoft tissueDesmoplastic small-round-cell tumorStromaVimentinSarcoma Diagnosis and TreatmentNeurofibromatosis and Schwannoma CasesPeptidase Inhibition and Analysis
NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker | Litcius